TrialInvestigational new drugs2014

Targeting DNA repair with combination veliparib (ABT-888) and temozolomide in patients with metastatic castration-resistant prostate cancer.

Maha Hussain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.